TCL Archive In Brief: One More Committee Review Needed for L.A., Rhode Island; Animal Tests In Factories (?) May 13, 1977
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
